The DOI matches its Crossref record.
Pregabalin and the Risk for Opioid-Related Death: A Nested Case–Control Study
Open accessAbstract
Letters20 November 2018Pregabalin and the Risk for Opioid-Related Death: A Nested Case–Control StudyTara Gomes, MHSc, PhD, Simon Greaves, MSc, Wim van den Brink, MD, PhD, Tony Antoniou, PharmD, PhD, Muhammad M. Mamdani, PharmD, MA, MPH, J. Michael Paterson, MSc, Diana Martins, MSc, and David N. Juurlink, MD, PhDTara Gomes, MHSc, PhDLi Ka Shing Knowledge Institute of St. Michael's Hospital, Institute for Clinical Evaluative Sciences, and University of Toronto, Toronto, Ontario, Canada (T.G., T.A., M.M.M.), Simon Greaves, MScInstitute for Clinical Evaluative Sciences, Toronto, Ontario, Canada (S.G.), Wim van den Brink, MD, PhDAcademic Medical Center University of Amsterdam, Amsterdam, the Netherlands (W.V.), Tony Antoniou, PharmD, PhDLi Ka Shing Knowledge Institute of St. Michael's Hospital, Institute for Clinical Evaluative Sciences, and University of Toronto, Toronto, Ontario, Canada (T.G., T.A., M.M.M.), Muhammad M. Mamdani, PharmD, MA, MPHLi Ka Shing Knowledge Institute of St. Michael's Hospital, Institute for Clinical Evaluative Sciences, and University of Toronto, Toronto, Ontario, Canada (T.G., T.A., M.M.M.), J. Michael Paterson, MScInstitute for Clinical Evaluative Sciences and University of Toronto, Toronto, Ontario, Canada (J.M.P.), Diana Martins, MScLi Ka Shing Knowledge Institute of St. Michael's Hospital, Toronto, Ontario, Canada (D.M.), and David N. Juurlink, MD, PhDInstitute for Clinical Evaluative Sciences, Sunnybrook Research Institute, and University of Toronto, Toronto, Ontario, Canada (D.N.J.)Author, Article, and Disclosure Informationhttps://doi.org/10.7326/M18-1136 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Background: Pregabalin is an anticonvulsant that is increasingly being prescribed as an adjunct for chronic pain (1, 2). However, it can be sedating and may augment central nervous system (CNS) depression in patients also receiving opioids (3). Because recent evidence shows that concomitant opioid and gabapentin use is associated with opioid-related mortality (4), understanding whether similar risks exist when pregabalin is coprescribed with opioids is essential.Objective: To examine the risk for opioid-related death among persons coprescribed pregabalin and opioids.Methods and Findings: We conducted a population-based, nested case–control study of Ontario residents eligible for public drug coverage who received ...References1. Toth C. Drug safety evaluation of pregabalin. Expert Opin Drug Saf. 2012;11:487-502. [PMID: 22468635] doi:10.1517/14740338.2012.677026 CrossrefMedlineGoogle Scholar2. Goodman CW, Brett AS. Gabapentin and pregabalin for pain—is increased prescribing a cause for concern? N Engl J Med. 2017;377:411-4. [PMID: 28767350] doi:10.1056/NEJMp1704633 CrossrefMedlineGoogle Scholar3. Bockbrader HN, Wesche D, Miller R, Chapel S, Janiczek N, Burger P. A comparison of the pharmacokinetics and pharmacodynamics of pregabalin and gabapentin. Clin Pharmacokinet. 2010;49:661-9. [PMID: 20818832] doi:10.2165/11536200-000000000-00000 CrossrefMedlineGoogle Scholar4. Gomes T, Juurlink DN, Antoniou T, Mamdani MM, Paterson JM, van den Brink W. Gabapentin, opioids, and the risk of opioid-related death: a population-based nested case-control study. PLoS Med. 2017;14:e1002396. [PMID: 28972983] doi:10.1371/journal.pmed.1002396 CrossrefMedlineGoogle Scholar5. Kwok H, Khuu W, Fernandes K, Martins D, Tadrous M, Singh S, et al. Impact of unrestricted access to pregabalin on the use of opioids and other CNS-active medications: a cross-sectional time series analysis. Pain Med. 2017;18:1019-26. [PMID: 28340102] doi:10.1093/pm/pnw351 CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAffiliations: Li Ka Shing Knowledge Institute of St. Michael's Hospital, Institute for Clinical Evaluative Sciences, and University of Toronto, Toronto, Ontario, Canada (T.G., T.A., M.M.M.)Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada (S.G.)Academic Medical Center University of Amsterdam, Amsterdam, the Netherlands (W.V.)Institute for Clinical Evaluative Sciences and University of Toronto, Toronto, Ontario, Canada (J.M.P.)Li Ka Shing Knowledge Institute of St. Michael's Hospital, Toronto, Ontario, Canada (D.M.)Institute for Clinical Evaluative Sciences, Sunnybrook Research Institute, and University of Toronto, Toronto, Ontario, Canada (D.N.J.)See also: Editorial comment (page 727).Note: The funding source had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Mr. Greaves had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.Disclaimer: The opinions, results, and conclusions reported here are those of the authors and are independent from those of the funding sources. No endorsement by the Institute for Clinical Evaluative Sciences or the Ontar
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022
Dowell, D., Ragan, K. R., Jones, C. M., Baldwin, G. T., & Chou, R. (2022) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr7103a1 · Cited by 1,886
Use of Opioids for Adults With Pain From Cancer or Cancer Treatment: ASCO Guideline
Paice, J. A., Bohlke, K., Barton, D., Craig, D. S., El-Jawahri, A., Hershman, D. L., Kong, L. R., Kurita, G. P., LeBlanc, T. W., Mercadante, S., et al. (2023) · Journal of Clinical Oncology · doi:10.1200/jco.22.02198 · Cited by 304
The Lancet Series call to action to reduce low value care for low back pain: an update
Buchbinder, R., Underwood, M., Hartvigsen, J., & Maher, C. G. (2020) · Pain · doi:10.1097/j.pain.0000000000001869 · Cited by 290
Understanding buprenorphine for use in chronic pain: expert opinion
Webster, L., Gudin, J., Raffa, R. B., Kuchera, J., Rauck, R., Fudin, J., Adler, J., & Mallick-Searle, T. (2020) · Pain Medicine · doi:10.1093/pm/pnz356 · Cited by 130
A cross sectional study of psychotropic medicine use in Australia in 2018: a focus on polypharmacy
Brett, J., Pearson, S., Daniels, B., Wylie, C. E., & Buckley, N. A. (2021) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14527 · Cited by 18
Metadata
- Authors
- Gomes, T., Greaves, S., van den Brink, W., Antoniou, T., Mamdani, M. M., Paterson, J. M., Martins, D., & Juurlink, D. N.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2018-11-20
- Volume
- 169
- Issue
- 10
- Pages
- 732-734
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2888071069
- Cited by
- 165
- References
- 0
- FWCI
- 20.48
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pregabalin and the Risk for Opioid-Related Death: A Nested Case–Control Study. https://app.cochat.ai/papers/10.7326/m18-1136
- The paper
- Gomes, T., Greaves, S., van den Brink, W., Antoniou, T., Mamdani, M. M., Paterson, J. M., Martins, D., & Juurlink, D. N. (2018). Pregabalin and the Risk for Opioid-Related Death: A Nested Case–Control Study. Annals of Internal Medicine. https://doi.org/10.7326/m18-1136
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.